For low- and middle-income countries, just obtaining doses has been a challenge. And now concerns are being raised about the effectiveness of the more affordable AstraZeneca option.
South Africa is a case study of the inequities around the coronavirus vaccine. It has one of the world's worst outbreaks, fueled by a new variant. Yet officials are struggling to buy enough vaccines.
The Democratic Republic of Congo beat its second-worst outbreak of the Ebola virus in June. The new victims indicate the disease's resurgence in the area.
Coronavirus infection rates in Kenya are the lowest they have been since the beginning of the pandemic, and life seems back to normal. A new song is capturing that moment.
A study raised concerns about its effectiveness against the coronavirus variant sweeping through the country — although the data is too preliminary for definitive conclusions.
New results from a COVID-19 vaccine trial in South Africa suggest the vaccine that was developed by AstraZeneca may not be as effective against the variant found there.
NPR's Audie Cornish speaks with Dr. Katherine O'Brien, of the World Health Organization, about the global landscape of COVID-19 vaccinations and why the WHO sent 90 million doses to Africa.